A Study to evaluate effect of AZD6234 as an adjunct to incretin-based therapies in adult participants with obesity or overweight with weight-related comorbidity with or without Type 2 Diabetes Mellitus

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2026
This article has no abstract
Epistemonikos ID: 48f3d95d10a371ff5b82ec2bc096c1547eb93fe1
First added on: Nov 01, 2026